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1. Introduction 
We have described the synthesis of a substance P 
analogue, <Glu-Gln-Phe-MePhe-MeGly-Leu- 
Met-NH2 [ 11. The peptide, referred to herein as 
DiMeC7, was designed to be resistant to a substance 
P degrading enzyme purified from brain [2]. Evidence 
for the increased stability of DiMeC7 in rat brain 
preparations has been presented [l]. Moreover, DiMe- 
C7 exhibited a high potency in competing for tritiated 
substance P binding to rat brain membranes as well as 
retaining biological activities in peripheral substance P 
bioassays [ 11. This report describes the synthesis of 
the precursor, production of the radiolabelled peptide 
by catalytic dehalogenation and further evidence for 
enhanced resistance of DiMeC7 to in vitro and in 
vivo digestion by rat brain compared with substance P. 
2. Materials and methods 
2.1 .Materials 
Polyacrylamide resin [4].(0.3 mmol sarcosine/g 
resin) was from Imperial Chemical Industries Ltd. 
Fmoc-Gln-p-nitrophenylester and Fmoc-Leu were 
purchased from Chemical Dynamics Co. For the prep- 
aration of Fmoc-MeGly and Fmoc-MePhe see [l] and 
for Fmoc-Phe (I) see [5]. 
Abbreviations: DCC, dicyclohexylcarbodiimide; DMF, N,N- 
dimethylformamide; Fmoc, fluorenyhnethoxycarbonyl; 
<Glu, pyroglutamic acid; HPLC, high-pressure liquid chro- 
matography; MeGly, N-methyl-glycine (sarcosine); MePhe, 
N-methyl-L-phenylalanine; ND, not determined; Phe(I), 
4-iodo_L-phenylalanine; TLC, thin-layer chromatography; 
VTA, ventral tegmental area 
Dimethylacetamide was obtained from East Anglia 
Chemicals and redistilled under vacuum. Plperidine 
was redistilled over KOH and kept in the dark. Tritium 
gas (98%) was purchased from the Radiochemical 
Centre, Amersham, Bucks. Solid phase synthesis was 
carried out using a VEGA model 50 peptide synthesizer. 
2.2. Analytical methods 
High-pressure liquid chromatography (HPLC) of 
the unlabelled peptide was carried out using a Du Pont 
model 850 HPLC system with a spectrophotometer 
model 852 and a column compartment model 850 in 
conjunction with one of the following isocratic 
reverse-phase systems: (A) p-Bondapak Cra, CHaCN/ 
50 mM H3P04, 3 1:69 (v/v); (B) p-Bondapak Cra, 
CHaCN/lO mM NH,OAc (pH 4.0), 35:65 (v/v); (C) 
Zorbax TMS, CHaCN/SO mM H3P04, 18:82 (v/v). 
All runs were performed at 35’C at a flow rate of 
2 ml/mm 
Analysis by HPLC of the radioactive product was 
effected on columns (0.46 X 25 cm) of the stated 
phases using constant volume (20 ml) gradients with 
the following solvent systems: (D) Nucleosil 10 Cra, 
CHsCN/18 mM HaPO, (from 25:75 to 50:50, v/v); 
(E) Nucleosil 10 CN, CH&N/18 mM H3P04 (from 
25:75 to 50:50, v/v); (F) Ph-bondapak, CH&N/O.2 N 
triethylammonium phosphate (pH 3.0) (from 25:75 
to 40:60, v/v). Flow rate was in the range of 1.5- 
2.0 ml/mm TLC analysis was on silica gel (Merck 
F254) using the following solvent systems: (G) 
n-BuOH:HOAc:HzO, 12:5:3; (H) n-PrOH:H?O, 7:3; 
(I) CHC13:CHa0H:NH40H, 60:45:20 and (J) EtOAc: 
CSHSN:HOAc:H20, 5:5:1:3. 
Amino acid analysis of the unlabelled peptide was 
performed as described in [l] and of the tritiated pep- 
tide as in [6]. 
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2.3. Solid phase synthesis: Gln-Gln-Phe(I)-MePhe- DiMe-C7 
MeGly-Leu-Met-resin (I) 
Boc-methionyloxycarbonylbenzoyl-alanyl-resin 
(0.30 mmol Met/g; 800 mg) was deprotected, neutral- 
ized and washed [ 1,7]. Fmoc-Leu, Fmoc--MeGly, 
Fmoc-MePhe, Fmoc-Phe(1) (12 equiv.) were pre- 
treated with DCC (6 equiv.) in dichloromethane to 
give symmetrical anhydrides. The solvent was removed, 
and the anhydrides were dissolved in dimethylacet- 
amide and added to the peptide-resin. Coupling of 
Fmoc-MePhe was followed by acetylation and in the 
case of Fmoc-Phe(1) a double coupling was performed 
prior to acetylation. Glutamine was incorporated via 
an active ester coupling. The peptide-resin was treated 
with hydroxybenzotriazole (6 equiv.) before addition 
of Fmoc-Gln-p-nitrophenyl ester (6 equiv.). Com- 
pletion of coupling reactions was demonstrated by 
the ninhydrin test in [S]. After complete synthesis, 
900 mg peptide-resin was recovered. 
it 
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2.4. <Glu-Gln-Phe(I)-MePhe-MeGly-Leu-Met- 
NH, (II) 
Fig.1. High-pressure liquid chromatography of crude <Glu- 
Gln-Phe(I)-MePhe-MeGly-Leu-Met-NH, on a semi-prep- 
arative C,, p-Bondapak reverse-phase (0.79 X 30 cm) column. 
Elution was done at room temperature, with a 15 mm linear 
gradient of CH,CN/lO mM NH,OAc pH 4.0 from 36:65 to 
58:42 (v/v) at a flow rate of 4 ml/mm For preparative runs, 
material corresponding to the main peak (elutmg at 9.6 mm) 
was collected and pooled. 
A portion (300 mg) of the heptapeptide-resin was 
subjected to amino-lysis for 25 h [5]. The peptide- 
material was dissolved in CHsCN/lO mM NH40Ac 
(PH 4.0), 5:95 (v/v) (10 ml) t HOAc (3 ml) and left 
at 64°C. After 48 h, virtually all heptapeptide was 
converted to <Glu-heptapeptide with no detectable 
side reaction. After evaporation the peptide material 
was dissolved in CHaOH (2 ml) and purified on a semi- 
preparative Cie (0.79 X 30 cm) column in portions 
(300-400 A), using a 15 min linear gradient of 
CHs CN/lO mM NH.,OAc @H 4.0) (from 35 :65 to 
58:42, v/v) and flow rate of 4 ml/min (fig.1). The 
material corresponding to the main peak was collected, 
the CHsCN was removed by evaporation and the sam- 
ple was lyophilized twice giving 20.0 mg (40%) analyt- 
ically pure peptide. Ammo acid analysis: Glu t Gln, 
2.10; Phe(I), 0.91; MePhe, ND; Sar, ND; Leu, 0.96; 
Met, 1.02. 
2.5. <Glu-Gln-[3H]Phe-MePhe-MeGly-Leu- 
CH30H (100 pl) and put through a 0.5 ml column of 
Dowex-1 (acetate). After evaporation the residue was 
dissolved in Hz O/HOAc (4: 1, v/v, 0.5 ml) and applied 
to a column (0.7 X 50 cm) of Nucleosil 10 Cra. The 
column was eluted at 6 ml/min with constant volume 
gradient (100 ml) of CH3CN/H20/H3P0, (from 250: 
750: 1 to 500:500: 1). The elute was monitored at 
210 nM and fractions (0.5 min) were collected auto- 
matically. Fractions containing the main peak judged 
by the W trace, were pooled and the volume was 
reduced by evaporation. The sample was passed 
through a column (1 ml) of Dowex 1 (acetate form) 
resin. After evaporation the sample was dissolved in 
Hz0 and stored in liquid N2 at 3.63 mCi/ml. Amino 
acid analysis: Glu t Gln, 2.02 (-); Phe, 1 .OO (-); 
MePhe, ND(-)MeGly ND (-); Leu, 1 .Ol (1 .Ol);Met, 
0.95 (1 .OO); NH3, 3.16 (1.28). (Figures in brackets are 
after enzyme hydrolysis.) 
Met-NH (III) 
A solution of compound (II) (25.4 mg; 2.5 pmol) 
in DMF (0.5 ml) was stirred with 98% 3Hz gas (3.2 ml, 
8 Ci) in the presence of 10% W/C (6.3 mg) and 5% 
Rh/CaC03 (6.8 mg). After 40 min, the catalysts were 
removed by filtration through TLC-grade cellulose 
and the filtrate was evaporated. The residue was dis- 
solved in Hz0 (1 ml), HOAc (50 pl), DMF (50 pl), 
2.6. Analytical characterization of II and III 
The purity of II was assessed by HPLC using the 
reverse-phase systems A-C (see section 2.2). The 
only impurity detectable was the sulphoxide. The 
purity of the preparation was also confirmed by thin- 
layer chromatography (TLC) using the systems G-H. 
Chromatographic purity of III after 28 days storage 
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Fig.2. (A) Cross-reactivity of standard DiMe-C7 and [ ‘H]DiMeC7 in a substance P radioimmunoassav. The dilution curves for 
DiMeC7 (-o-o-) and [3H]DiMeC7 (-A-A-) are identical, but not parallel to that for standard substance P (--e-e-). The 
cross-reactivity relative to substance P against he C-terminal-directed guinea pig antiserum [lo] is 0.005. Concentrations for stan- 
dard substance P and DiMeC7 were determined by amino acid analyses of stock solutions. The dotted line marks blank values 
(8%): B, antiserum bound tracer; F, free (unbound) tracer. (B) Contractile potencies of DiMeC7 (-o-c-) and [‘H]DiMeC7 
(-A--A--) compared with standard substance P (-e-e-) on the guinea pig ileum. Potencies were tested in the presence of 1 PM 
atropine sulphate, 1nM mepyramine maleate, and 10 PM tryptamine hydrochloride. 
at -196°C was determined by systems D-F. The 
purity was estimated to be 95.6-97.0% with the main 
impurity being sulphoxidized peptide (2 .l-2.4%). 
TLC in solvent systems H-J revealed similar value, 
94.S97.3% and 2.4-3.7% sulphoxidized peptide. 
The distribution of radioactivity amongst the amino 
acid residues was 98.0% in Phe and 0.4% in Met. 
2.7. Guinea pig ileum assay 
The experimental details for assessing spasmogenic 
activity on guinea pig ileum have been given in [2]. 
In this assay, [3H]DiMe-C7 was equipotent to the un- 
labelled material. The dose-response curves were 
superimposable (fig.ZB), and the potency relative to 
substance P was 0.046*. 
2.8. Radioimmunoassay (RIA) 
RJA was performed as in [9] using a substance P 
C-terminus directed antiserum raised in guinea pig. In 
* Note that the value was obtained in the presence of 1 PM 
atropine; a higher potency is obtained in the absence of 
atropine, as reported in [ l] 
this assay the tritiated peptide behaved exactly as the 
non-radioactive material (fig2A). The cross-reactivity 
relative to substance P against the C-terminal-directed 
guinea pig antiserum was 0.005. 
2.9. Metabolic stability - rat brain synaptosomes 
[3H]DiMe-C7 (198 pmol) was added to 20 mM 
Hepes (pH7.4)(500~)containingOS%bovine s rum 
albumin and 1 mg membrane protein of a rat whole 
brain P2B fraction [lo]. After incubation for 30 min 
at 37”C, 6 M HCl(lO0 4) was added to the sample 
and the sample was clarified by centrifugation through 
a 0.2 I.tm Teflon filter (Bioanalytical Systems). The 
clarified supernatant (25 4) was analysed by reverse- 
phase HPLC on a @ondapak Crs (0.39 X 30 cm) 
column. Samples were eluted with a 20 mm linear 
gradient of CH3CN/50 mM H3P04 (from 5 95 (v/v) 
to 65:35 (v/v)) at a flow rate of 2 ml/min at room 
temperature. The elution position of DiMeC7 was 
determined’by calibration runs using synthetic DiMe- 
C7 detected by absorbance at 220 nm. Fractions 
(0.2 mm) were counted for radioactivity by liquid 
scintillation and corrected for quenching. 
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Fig.3. HPLC analysis of [‘HIDiMe< before (-o-o-) and 
after (-o--o-_) incubation with a rat brain P,B fraction. The 
arrow marks the elution position of standard synthetic 
DiMeC7. The radiochemical recoveries of the applied sam- 
ples were 110% of 9.9 pmol for the ‘before’ sample, and 82% 
of 8.25 pmol for the ‘after’ sample. 
2.10. Metabolic stability - in vivo brain microinfision 
A solution 1.2 I.cg/ml(2 4) of [ 3H] DiMe-C7 (diluted 
with standard synthetic DiMe-C7 to spec. act. 2.95 Gil 
mmol) in 0.9% saline was infused into the rat brain 
ventral tegmental rea (VTA) using an implanted guide 
cannula [l 11. The sample was injected over 2 min and 
then at least 1 min was allowed for sample diffusion. 
Rats were killed by decapitation at intervals after 
injection, and the VTA was quickly dissected on ice 
and frozen. The frozen regions were weighed, homog- 
enised and extracted for 5 mm in boiling 1 M HOAc 
(10 vol.). The extract was centrifuged for 5 min at 
10 000 X g at room temperature in a Beckman Micro- 
fuge’. The supernatant was freeze-dried and the residue 
extracted with absolute thanol (100 ~1). Duplicate 
samples (20 /.tl) of the ethanol extract were counted 
by liquid scintillation, and a sample (20 /.d) was applied 
to LQD silica gel plates (Quantum Industries). Plates 
were developed in TLC system H, dried, and scanned 
for radioactivity with a Berthold thin-layer chromat- 
ogram scanner. Markers [3H] DiMe-C7 and standard 
DiMeC7 were included on each plate. The latter was 
visualised by chlorine/o-tolidine treatment. Both un- 
labelled and labelled markers were largely oxidised 
during application to the thin-layer plate: thus, 
extracted samples were expected to be largely, if not 
wholly, in the oxidised form. Possible degradation 
first appeared at 50 mm, as determined by the appear- 
ance of radioactive products which did not co-migrate 
with the oxidised or unmodified DiMe-C7 standards. 
3. Results and discussion 
A radiolabelled enzyme-resistant substance P 
analogue [ 3H] DiMe-C7, was synthesised and com- 
pared to the unlabelled peptide. The identity of the 
compound was confirmed by physico-chemical and 
biological criteria. In all cases the radiolabelled pep- 
tide and the non-labelled compound exhibited iden- 
tical properties. The specific radioactivity (18.3 Ci/ 
mmol) was lower than theoretical, but high enough 
to be used as a radio&and in receptor-binding studies 
[3]. DiMe-C7 has been demonstrated to be completely 
stable when exposed to substance P-degrading enzyme 
as well as to a rat hypothalamic slice preparation [ 11. 
However, in the latter case a relatively high concen- 
tration of the peptide had to be used because peptide 
levels were monitored by immunoreactivity and 
DiMe-C7 cross-reacted poorly with the C-terminus 
directed substance P antiserum. With the tritiated 
peptide we have been able to test metabolic stability 
Fig.4. Radioactivity scans of thin-layer chromatograms of 
[sH]DiMeC7 and other products recovered after in vivo 
infusion into the rat brain ventral tegmental area. Reanalysis 
by HPLC of chromatographed material confirmed the TLC 
results. 
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at much lower peptide concentrations. When substance 
P is treated with a rat synaptosomal preparation, the 
peptide is split by endopeptidase attack [2] and the 
inactivation of substance Pis complete within minutes. 
When DiMe-C7 was exposed to the same conditions 
no degradation of the peptide was detectable up to 
30 min. 
Stereotactic injection of [3H]DiMe-C7 into VTA 
of the rat brain showed that the injected peptide 
remained substantially intact even 50 min after the 
infusion whereas the same amount of substance P was 
completely degraded after <lO min. The combination 
of high biological potency, enzymatic resistance and 
lack of charged groups (likely to decrease some types 
of adsorption), makes the radiolabelied version of 
DiMe-C7 potentially useful probe of substance P 
receptors. 
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